Clinical Trial NCT05539248
Trial
Care Pharma – CAN 106-PNH- 102/201 (NCT05539248)
Clinical trial ID
NCT05539248
Drug name
CAN106
Company:
Care Pharma
Drug trade name
---
Clinicaltrials.gov
Learn more
Phase of study
2
Current status
Recruiting
Start
03/2022
Substance
Monoclonal antibody
Research question
Assessment of safety, tolerability, efficacy, pc and pc in complement- inhibitor treatment- naive and pretreated adults
Delivery method of drug
i.v.
Frequency
every 4 or every 8 weeks
Clinical trial locations
China